Pharmacognosy Communications

Pharmacognosy Communications

Pharmacognosy Communications, Vol 14, Issue 4, Oct-Dec, 2024

Published: 18 November 2024

Editorial

Pharmacognosy Communications, 14 (4), 2024, 137.

DOI: 10.5530/pc.2024.4.22

Read Full Text PDF

Published: 18 November 2024 Original Article

Assessment of the Phytochemical Composition and Antioxidant Properties of Ripe Fruit of Cucumis metuliferus E. Meyer Ex. Naudin

Ishaku Leo Elisha, Joy Gararawa Usman, Monday Michael Onakpa, Olatunde Peter Ajagbonna, Saka Sanni, Usman Ngamarju Gadzama

Pharmacognosy Communications, 14 (4), 2024, 138-143.

DOI: 10.5530/pc.2024.4.23

Read Full Text PDF

Published: 18 November 2024 Original Article

Interactive Antibacterial Activity and Toxicity Profiles of Selected Pure Plant Compounds and Conventional Antibiotics Against Bacterial Triggers of Some Autoimmune Diseases

Audric Puisais, Ian Edwin Cock

Pharmacognosy Communications,, 14 (4), 2024, 144-154.

DOI: 10.5530/pc.2024.4.24

Read Full Text PDF

Published: 18 November 2024 Original Article

Terminalia bellericia (Gaertn.) Roxb. Fruit Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases and Potentiate the Activity of Conventional Antibiotics

Ian Edwin Cock, Kun Wang, Mengqi Xiao

Pharmacognosy Communications, 14 (4), 2024, 155-167.

DOI: 10.5530/pc.2024.4.25

Read Full Text PDF

Published: 18 November 2024 Original Article

Tasmannia lanceolata (Poir.) A.C. Sm. Berry Extracts Inhibit the Growth of the Skin Pathogens Staphylococcus aureus and Staphylococcus epidermidis

Ian Edwin Cock, Veronica Winnett

Pharmacognosy Communications, 14 (4), 2024, 168-174.

DOI: 10.5530/pc.2024.4.26

Read Full Text PDF

Published: 18 November 2024 Original Article

Hamamelis virginiana L. Leaf Extracts Inhibit Some Bacterial Triggers of Selected Autoimmune Inflammatory Diseases

Cindy Nguyen, Ian Edwin Cock

Pharmacognosy Communications, 14 (4), 2024, 175-184.

DOI: 10.5530/pc.2024.4.27

Read Full Text PDF

Published: 18 November 2024 The Janus Corner

The Venom of One of the World’s Most Deadly Spiders may Provide a Novel Drug to Treat Heart Attack and Stroke Patients and Save Lives

Pharmacognosy Communications, 14 (4), 2024, 185-186.

DOI: 10.5530/pc.2024.4.28

Read Full Text PDF

Published: 18 November 2024 Medicinal Plant Images

Medicinal Plant Images

Pharmacognosy Communications, 14 (4), 2024, 187-188.

DOI: 10.5530/pc.2024.4.29

Read Full Text PDF

Published: 20 November 2024 Upcoming Events

Upcoming Events

Pharmacognosy Communications, 14 (4), 2024, 189-189.

DOI:

Read Full Text PDF

Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.